Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors

Nanoscale Horizons(2025)10.1039/d5nh00206kSource: DataRank Database

Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors is a research paper published in Nanoscale Horizons (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.30)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Haeik Park,Wenan Qiang ORCID,Ge Lin ORCID,Sultan Almunif ORCID,Swagat Sharma ORCID

Live enrichment

PubMed:40552380 PMC:PMC12186146 OpenAlex:https://openalex.org/W4411575368

National Institutes of Health

Grant: T32GM008449

NIGMS NIH HHS

Grant: T32 GM149439

National Institutes of Health

Grant: 5T32GM008449-14

Biotechnology Predoctoral Training Program

FWCI

0.30

Citation Percentile

0.5%

Citation Trend

2026

hybridLicense: cc-by-nc

journalhttps://pubs.rsc.org/en/content/articlepdf/2025/nh/d5nh00206k

publisherhttps://pubs.rsc.org/en/content/articlepdf/2025/nh/d5nh00206k

publisherhttp://pubs.rsc.org/en/content/articlepdf/2025/NH/D5NH00206K

journalhttps://doi.org/10.1039/d5nh00206k

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40552380

Fields of Study

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsMonoclonal and Polyclonal Antibodies Research02 engineering and technology0210 nano-technology

MeSH Terms

AnimalsAntibodies, MonoclonalColonic NeoplasmsFemaleHumansMelanomaNeoplasmsPinocytosisTissue DistributionBridged Bicyclo Compounds, HeterocyclicCell Line, TumorMiceNanoparticlesThiazolidinesTumor MicroenvironmentProgrammed Cell Death 1 Receptor

Keywords

PinocytosisToxicityInhibitory postsynaptic potentialNanoparticleAntibodyPharmacologyChemistryMedicineCancer researchNanotechnologyInternal medicineImmunologyMaterials scienceReceptorEndocytosisProgrammed Cell Death 1 ReceptorAntibodies, MonoclonalBridged Bicyclo Compounds, HeterocyclicMiceCell Line, TumorNeoplasmsColonic NeoplasmsTumor MicroenvironmentAnimalsNanoparticlesHumansThiazolidinesTissue DistributionFemaleMelanoma